Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - vancomycin hydrochloride - pdr/conc/soln for infus - 500 milligram - vancomycin - antibacterials for systemic use: glycopeptide antibacterials - it is used for severe infections, caused by gram-positive bacteria susceptible to vancomycin which cannot be treated with or failed to respond or are resistant to other antibiotics such as penicillins and cephalosporins

Malta - English - Medicines Authority

apta medica internacional d.o.o likozarjeva ulica 6, 1000 ljubljana, , slovenia - vancomycin - powder for concentrate for solution for infusion - vancomycin 50 mg/ml - antibacterials for systemic use

Malta - English - Medicines Authority

apta medica internacional d.o.o likozarjeva ulica 6, 1000 ljubljana, , slovenia - vancomycin - powder for concentrate for solution for infusion - vancomycin 50 mg/ml - antibacterials for systemic use

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - vancomycin hydrochloride 513mg equivalent to 500 mg vancomycin;  ;   - powder for infusion - 500 mg - active: vancomycin hydrochloride 513mg equivalent to 500 mg vancomycin     - vancomycin hydrochloride is indicated for potentially life-threatening infections which cannot be treated with another effective, less toxic antimicrobial drug, including the penicillins and cephalosporins. vancomycin hydrochloride is useful in therapy of severe staphylococcal (including methicillin resistant staphylococcal) infections in patients who cannot receive or who have failed to respond to the penicillins and cephalosporins or who have infections with staphylococci that are resistant to other antibiotics. once sensitivity data are available, therapy should be adjusted accordingly. vancomycin hydrochloride is effective alone or in combination with an aminoglycoside for endocarditis caused by streptococcus viridans or s. bovis. for endocarditis caused by enterococci (e.g. strep. faecalis), vancomycin hydrochloride is effective only in combination with an aminoglycoside. vancomycin hydrochloride is effective for the treatment of diptheroid endocarditis. vancomycin hydrochloride is used in combination with rifampicin, an aminoglycoside, or both in early-onset prosthetic valve endocarditis caused by staph. epidermidis or diptheroids. the effectiveness of vancomycin has been documented in other infections due to staphylococci including osteomyelitis, pneumonia, septicaemia and skin and skin structure infections. when staphylococcal infections are localised and purulent, antibiotics are used as adjuncts to appropriate surgical measures. specimens for bacteriological cultures should be obtained in order to isolate and identify causative organisms and to determine their susceptibilities to vancomycin hydrochloride. vancomycin hydrochloride should be administered orally for the treatment of staphylococcal enterocolitis and antibiotic-associated pseudomembranous colitis (produced by c. difficile). parenteral administration of vancomycin hydrochloride alone is inappropriate for this indication.

United States - English - NLM (National Library of Medicine)

sagent pharmaceuticals - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin 5 g in 100 ml - vancomycin hydrochloride for injection, usp is indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (β-lactam-resistant) staphylococci. it is indicated for penicillin-allergic patients, for patients who cannot receive or who have failed to respond to other drugs, including the penicillins or cephalosporins, and for infections caused by vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. vancomycin hydrochloride for injection, usp is indicated for initial therapy when methicillin-resistant staphylococci are suspected, but after susceptibility data are available, therapy should be adjusted accordingly. vancomycin hydrochloride for injection, usp is effective in the treatment of staphylococcal endocarditis. its effectiveness has been documented in other infections due to staphylococci, including septicemia, bone infections, lower respiratory tract infections, skin and skin structure infections. when staphylococcal infecti

United States - English - NLM (National Library of Medicine)

heritage pharmaceuticals inc. d/b/a avet pharmaceuticals inc. - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin 10 g in 80 ml - vancomycin hydrochloride for injection, usp is indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (β-lactam-resistant) staphylococci. it is indicated for penicillin-allergic patients, for patients who cannot receive or who have failed to respond to other drugs, including the penicillins or cephalosporins, and for infections caused by vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. vancomycin hydrochloride for injection, usp is indicated for initial therapy when methicillin-resistant staphylococci are suspected, but after susceptibility data are available, therapy should be adjusted accordingly. vancomycin hydrochloride for injection, usp is effective in the treatment of staphylococcal endocarditis. its effectiveness has been documented in other infections due to staphylococci, including septicemia, bone infections, lower respiratory tract infections, skin and skin-structure infections. when staphylococcal infecti

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - vancomycin hydrochloride - powder for concentrate for solution for infusion - 1000 milligram(s) - glycopeptide antibacterials; vancomycin

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - vancomycin hydrochloride - powder for concentrate for solution for infusion - 500 milligram(s) - glycopeptide antibacterials; vancomycin

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - vancomycin hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - vancomycin hydrochloride -